Falsified Medicines Directive

The Falsified Medicines EU Directive 2011/62/EU is in force from 2 July 2013 and requires each import of an API from a country outside the EU to be accompanied by a written confirmation to ensure patient safety and controlled trading.

Fagron is compliant with this new directive. Suppliers are only being approved after going through the Fagron Group supplier qualification process, which also includes on-site audits. Fagron thus ensures patient safety and product availability worldwide.